The pharmaceutical plant, built in Kigali by leading Moroccan drug maker Cooper Pharma, will be operational in July, announced the local representative of Cooper Pharma. Once fully operational, the plant is expected to help Rwanda save millions of dollars spent annually on imports of medicines. Ayman Cheikh Lahlou, the CEO of Cooper Pharma said that the Kigali plant is designed in accordance with European Good Manufacturing Practice (GMP) quality standards. Based in Casablanca since 1933, Cooper Pharma manufactures, imports, markets and promotes a hundred of drugs under license from more than 20 international companies. Cooper Pharma is one of several Moroccan firms seeking to expand their activities beyond domestic market.

Source: The North Africa Journal January 17, 2020 12:11 UTC